Navigation Links
Stryker to Present at Investor Conferences
Date:9/3/2009

KALAMAZOO, Mich., Sept. 3 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that it will participate in the following investor conferences:

September 15, 2009 - 8:00 a.m. Eastern Time

Morgan Stanley Global Healthcare Unplugged Conference

New York, New York

September 22, 2009 - 2:00 p.m. Eastern Time

UBS Global Life Sciences Conference

New York, New York

A simultaneous webcast of the Company's presentations will be available on Stryker's website at www.stryker.com. The presentations for the Morgan Stanley Global Healthcare Unplugged Conference and the UBS Global Life Sciences Conference will be archived for 30 days.

Certain statements made in the presentations may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: further weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; unfavorable resolution of income tax audits; changes in finan
'/>"/>

SOURCE Stryker Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stryker to Host Conference Call on January 23, 2008
2. Stryker To Host Conference Call On July 17, 2008
3. Stryker to Host Conference Call on October 16, 2008
4. Stryker Announces Organizational Changes
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... July 24, 2015  Champions Oncology (OTC-BB: CSBR), a ... and services to personalize the development and use of ... and operational results for the fourth quarter and fiscal ... 28, 2015, before market open. The company ... that day at 9:00 a.m. EDT (6:00 a.m. PDT). ...
(Date:7/24/2015)... -- The global next generation sequencing ... by 2022, growing at an estimated CAGR of 40.1% ... by Grand View Research, Inc. Development of faster, more ... significant reduction in cost of sequencing one base pair. ... of next generation sequencing throughout the forecast period. Revenue ...
(Date:7/23/2015)... LOS ANGELES , July 23, 2015 ImmunoCellular ... plans to report financial results for the second quarter 2015 ... hold a conference call and webcast on that day at ... results and provide a business update. The call will be ...   , , , LIVE CALL: ...
(Date:7/23/2015)... ... July 23, 2015 , ... One hundred years ago ... 1915 National Model Aeroplane Competition, with hopes of winning the Henry S. Villard Trophy. ... centennial. , Participants will have the opportunity to build a Free Flight fantasy club ...
Breaking Biology Technology:Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5ImmunoCellular Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015 2Academy of Model Aeronautics to Start Online Fantasy Flight Competition 2
... NEW YORK, August 28 XTL Biopharmaceuticals,Ltd. (NASDAQ: ... biopharmaceutical company,engaged in the acquisition, development and commercialization ... particularly,neuropathic pain and hepatitis C, today announced that ... Company,s depositary bank,The Bank of New York, will ...
... PARIS, August 28 ExonHit Therapeutics, a drug,and ... discovery,collaboration with Allergan Inc. (NYSE: AGN ), ... reached a success milestone.,As a result of the ... human,clinical testing will be initiated on the first ...
... (Nasdaq:,IDMI) today announced that Jeffrey W. Sherman, M.D., F.A.C.P. ... Senior Vice President,of Research and Development. Dr. Sherman will ... and CEO Timothy P. Walbert. Dr. Sherman brings ... and will lead the regulatory and clinical strategy for ...
Cached Biology Technology:Processing Fees on ADRs to be Waived for two Months 2Processing Fees on ADRs to be Waived for two Months 3ExonHit Therapeutics: Allergan and ExonHit's First Collaboration Compound to Begin Human Clinical Trials 2ExonHit Therapeutics: Allergan and ExonHit's First Collaboration Compound to Begin Human Clinical Trials 3IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 2IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 3IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 4IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 5
(Date:7/21/2015)... Sweden , July 21, 2015 Today, ... FPC1025. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
(Date:7/13/2015)... JOSE, Calif. , July 13, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... generation touch and display driver integration (TDDI) product ... is the first to combine Synaptics , ... with proven display driver technology developed in the ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... The Federation of American Societies for Experimental ... the Science Research Conference (SRC): Glucose transport: Gateway ... Science Research Conference "Glucose transport: Gateway for Metabolic ... role of glucose transport in the control of ...
... of American Societies for Experimental Biology (FASEB) announces ... Conference (SRC): Mitochondrial Assembly and Dynamics in Health, ... Mitochondrial Assembly and Dynamics in Health, Disease and ... where diverse aspects of mitochondrial biology and dysfunction ...
... American Societies for Experimental Biology (FASEB) announces the ... (SRC): Neural Mechanisms in Cardiovascular Regulation. The ... Cardiovascular Regulation, is an important and unique scientific ... regulate normal cardiovascular function, and how dysregulation of ...
Cached Biology News:
PMM2 Immunogen: PMM2 (NP_000294, 47 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
HOXC11 Antibody...
Rabbit polyclonal to Raf1 ( Abpromise for all tested applications). entrezGeneID: 5894 SwissProtID: P04049...
Sheep polyclonal to hCG beta core fragment ( Abpromise for all tested applications). Antigen: Full length native protein (purified) from human urine. Entrez GeneID: 1082 Swiss Protein ID...
Biology Products: